title: Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro.
abstract: Initiation of reverse transcription in hepadnaviruses is accomplished by a unique protein-priming mechanism whereby a specific Y residue in the terminal protein (TP) domain of the viral reverse transcriptase (RT) acts as a primer to initiate DNA synthesis, which is carried out by the RT domain of the same protein. When separate TP and RT domains from the duck hepatitis B virus (DHBV) RT protein were tested in a trans-complementation assay in vitro, the RT domain could also serve, unexpectedly, as a protein primer for DNA synthesis, as could a TP mutant lacking the authentic primer Y (Y96) residue. Priming at these other, so-called cryptic, priming sites in both the RT and TP domains shared the same requirements as those at Y96. A mini RT protein with both the TP and RT domains linked in cis, as well as the full-length RT protein, could also initiate DNA synthesis using cryptic priming sites. The cryptic priming site(s) in TP was found to be S/T, while those in the RT domain were Y and S/T. As with the authentic TP Y96 priming site, the cryptic priming sites in the TP and RT domains could support DNA polymerization subsequent to the initial covalent linkage of the first nucleotide to the priming amino acid residue. These results provide new insights into the complex mechanisms of protein priming in hepadnaviruses, including the selection of the primer residue and the interactions between the TP and RT domains that is essential for protein priming.
authors: Department of Microbiology and Immunology-H107, The Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033, USA.
authors: Rajeev K
authors: RK
authors: Boregowda
authors: Li
authors: L
authors: Lin
authors: Qin
authors: Q
authors: Zhu
authors: Fang
authors: F
authors: Tian
authors: Jianming
authors: J
authors: Hu
references: Trends Biochem Sci. 2011 Apr;36(4):221-8
references: 21256032
references: J Virol. 2008 Jun;82(12):5703-14
references: 18400846
references: Connect Tissue Res. 1983;12(1):1-16
references: 6671378
references: J Virol. 2006 Mar;80(5):2141-50
references: 16474122
references: J Virol. 1998 Jul;72(7):5789-96
references: 9621038
references: Eur J Biochem. 1982 May;124(1):47-55
references: 6211353
references: J Virol. 1994 Sep;68(9):5579-87
references: 7520092
references: Methods Enzymol. 1983;99:387-402
references: 6196603
references: J Virol. 1990 Nov;64(11):5553-8
references: 1698997
references: J Virol. 2011 Aug;85(15):7742-53
references: 21593158
references: Cell. 1992 Nov 13;71(4):663-70
references: 1384989
references: Cell. 1982 Jun;29(2):403-15
references: 6180831
references: Annu Rev Biochem. 1991;60:39-71
references: 1883199
references: Methods Enzymol. 1991;201:149-52
references: 1943761
references: J Virol. 2007 Dec;81(24):13354-64
references: 17913810
references: Methods Enzymol. 1991;201:10-21
references: 1943759
references: J Virol. 2009 Jun;83(11):5815-24
references: 19297497
references: Virology. 2004 Apr 25;322(1):22-30
references: 15063113
references: J Virol. 1996 Sep;70(9):5741-50
references: 8709189
references: J Virol. 1994 Aug;68(8):5232-8
references: 8035519
references: Methods Mol Med. 2004;95:259-69
references: 14762309
references: J Virol. 1993 Nov;67(11):6507-12
references: 7692081
references: FEBS Lett. 1980 Feb 11;110(2):308-12
references: 15851356
references: Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2888-92
references: 1707174
references: J Virol. 1997 Apr;71(4):2996-3004
references: 9060659
references: PLoS Pathog. 2010 Jul 15;6(7):e1000986
references: 20657822
references: Nucleic Acids Res. 2007;35(18):6124-36
references: 17804463
references: J Virol. 2000 Dec;74(24):11447-55
references: 11090140
references: J Virol. 2004 Dec;78(23):13122-31
references: 15542664
references: J Virol. 1994 Jun;68(6):3536-43
references: 8189492
references: Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68
references: 10704474
references: J Virol. 1994 May;68(5):2994-9
references: 7512155
references: J Virol. 1994 Dec;68(12):8437-42
references: 7525990
references: EMBO J. 1990 Oct;9(10):3353-62
references: 1698615
references: BMC Biotechnol. 2008 May 16;8:51
references: 18485215
references: J Virol. 2008 Mar;82(5):2305-12
references: 18094191
references: Front Biosci (Landmark Ed). 2009 Jan 01;14:1606-18
references: 19273150
references: J Virol. 1994 Jan;68(1):6-13
references: 7504742
references: J Virol. 2010 Jan;84(1):52-8
references: 19776122
references: J Virol. 2001 Aug;75(16):7410-9
references: 11462013
references: J Virol. 2003 Apr;77(8):4471-80
references: 12663754
references: J Virol. 1990 Feb;64(2):613-20
references: 2153228
references: EMBO J. 1997 Jan 2;16(1):59-68
references: 9009268
references: Virology. 1995 Jun 1;209(2):315-26
references: 7778266
references: Virology. 2006 Jul 5;350(2):475-83
references: 16563457
references: Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1060-4
references: 8577714
references: J Virol. 2006 Aug;80(15):7405-15
references: 16840321
references: Methods Enzymol. 1996;275:195-208
references: 9026639
references: J Gen Virol. 2011 Feb;92(Pt 2):445-52
references: 21068217
references: J Biol Chem. 1982 Aug 25;257(16):9648-52
references: 6179934
references: J Virol. 2000 Sep;74(18):8648-57
references: 10954566
references: J Virol. 1995 Jul;69(7):4431-9
references: 7539509
references: J Virol. 2002 Jan;76(1):269-79
references: 11739692
references: J Virol. 2002 Jun;76(12):5857-65
references: 12021318
references: J Virol. 1999 Mar;73(3):1885-93
references: 9971767
references: J Virol. 1995 Jul;69(7):4283-91
references: 7769689
references: Nature. 1998 May 21;393(6682):280-4
references: 9607767